Fidelity Investments
TTOO

Fidelity Investments’s T2 Biosystems, Inc TTOO Stock Holding History

Fidelity Investments’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1
Closed -$21 – 5704
2023
Q3 		$21 Buy
+1
New +$26 ﹤0.01% 5085
2023
Q2 		– Hold
0
– – – 5635
2023
Q1 		– Hold
0
– – – 5244
2022
Q4 		– Hold
0
– – – 5226
2022
Q3 		– Hold
0
– – – 5513
2022
Q2 		– Hold
0
– – – 5616
2022
Q1 		– Hold
0
– – – 5612
2021
Q3 		– Hold
0
– – – 5182
2021
Q2 		– Hold
0
– – – 5027
2018
Q4 		– Hold
0
– -$15K – 4274
2018
Q3 		– Hold
0
– – – 3058
2015
Q1 		– Sell
-44
Closed -$4.19M – 2805
2014
Q4 		$4.19M Sell
44
-144
-77% -$11.9M ﹤0.01% 2281
2014
Q3 		$17M Buy
+188
New +$17.5M ﹤0.01% 1813

Other funds holding TTOO

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Fidelity Investments's TTOO Position: Q4 2023 in Review

Fidelity Investments sold out of T2 Biosystems, Inc (TTOO) in Q4 2023, closing a stake of 1 share — an estimated $21 sold.

Fidelity Investments first reported a position in TTOO in Q3 2014 and held it in 3 quarters. The position peaked at $17M in Q3 2014. 21 funds tracked by Wall St. Rank hold TTOO as of Q4 2023.

  • Fidelity Investments reported no remaining T2 Biosystems, Inc position as of Q4 2023 after selling out during the quarter.
  • Fidelity Investments sold 1 T2 Biosystems, Inc share in Q4 2023, an estimated $21.
  • Fidelity Investments first reported a position in T2 Biosystems, Inc in Q3 2014 and held it in 3 quarters.
  • Fidelity Investments's T2 Biosystems, Inc position peaked at $17M in Q3 2014.
  • 21 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2023.

Based on Fidelity Investments's 13F filing for Q4 2023, filed 13 Feb 2024.